Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, AVVAA World Health Care Products's enterprise value is $1.93 Mil.
AVVAA World Health Care Products's EBITDA for the trailing twelve months (TTM) ended in May. 2007 was $-1.99 Mil. Therefore, AVVAA World Health Care Products's EV-to-EBITDA for today is -0.97.
The historical rank and industry rank for AVVAA World Health Care Products's EV-to-EBITDA or its related term are showing as below:
AVVH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -0.97 Med: 0 Max: 0
Current: -0.97
AVVH's EV-to-EBITDA is not ranked
in the Banks industry.
Industry Median: 17.05
vs AVVH: -0.97
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
AVVAA World Health Care Products (OTCPK:AVVH) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
AVVAA World Health Care Products's PE Ratio (TTM) for today is calculated as:
AVVAA World Health Care Products's share price for today is $0.002.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AVVAA World Health Care Products's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2007 was $-3.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVVAA World Health Care Products EV-to-EBITDA Chart
AVVH vs PAPL, AAMCF, LFLS: EV-to-EBITDA Comparison
For the Mortgage Finance subindustry, AVVAA World Health Care Products's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AVVAA World Health Care Products EV-to-EBITDA vs Banks Industry
For the Banks industry and Financial Services sector, AVVAA World Health Care Products's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where AVVAA World Health Care Products's EV-to-EBITDA falls into.
AVVAA World Health Care Products's current Enterprise Value is $1.93 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AVVAA World Health Care Products's EBITDA for the trailing twelve months (TTM) ended in May. 2007 was $-1.99 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVVAA World Health Care Products (AVVH) has a EV-to-EBITDA of -0.97 as of Aug. 04, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on AVVAA World Health Care Products.
Is AVVAA World Health Care Products' EV-to-EBITDA too high?
AVVAA World Health Care Products' current EV-to-EBITDA is -0.97.
How does AVVAA World Health Care Products' EV-to-EBITDA compare to PAPL and AAMCF?
AVVAA World Health Care Products' EV-to-EBITDA of -0.97 can be compared against companies in the Banks industry. The industry median EV-to-EBITDA is 17.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Banks company?
The median EV-to-EBITDA among Banks companies is 17.05, based on 35 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on AVVAA World Health Care Products. For the Banks industry, the median EV-to-EBITDA is 17.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AVVAA World Health Care Products's current EV-to-EBITDA is -0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AVVAA World Health Care Products stock overvalued right now?
AVVAA World Health Care Products (AVVH) has a current EV-to-EBITDA of -0.97. The current EV-to-EBITDA is -0.97. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For AVVAA World Health Care Products (AVVH), the current EV-to-EBITDA is -0.97 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVVH has been successfully added to your 
